148 related articles for article (PubMed ID: 10449218)
1. The efficacy of L-Deprenyl in dogs with pituitary-dependent hyperadrenocorticism.
Reusch CE; Steffen T; Hoerauf A
J Vet Intern Med; 1999; 13(4):291-301. PubMed ID: 10449218
[TBL] [Abstract][Full Text] [Related]
2. Management of canine pituitary-dependent hyperadrenocorticism with l-deprenyl (Anipryl).
Bruyette DS; Ruehl WW; Entriken T; Griffin D; Darling L
Vet Clin North Am Small Anim Pract; 1997 Mar; 27(2):273-86. PubMed ID: 9076907
[TBL] [Abstract][Full Text] [Related]
3. Medical treatment of pituitary-dependent hyperadrenocorticism in dogs: should L-deprenyl (Anipryl) ever be used?
Peterson ME
J Vet Intern Med; 1999; 13(4):289-90. PubMed ID: 10449217
[No Abstract] [Full Text] [Related]
4. Use of urine cortisol:creatinine ratio versus adrenocorticotropic hormone stimulation testing for monitoring mitotane treatment of pituitary-dependent hyperadrenocorticism in dogs.
Angles JM; Feldman EC; Nelson RW; Feldman MS
J Am Vet Med Assoc; 1997 Oct; 211(8):1002-4. PubMed ID: 9343543
[TBL] [Abstract][Full Text] [Related]
5. Results of clinical examinations, laboratory tests, and ultrasonography in dogs with pituitary-dependent hyperadrenocorticism treated with trilostane.
Ruckstuhl NS; Nett CS; Reusch CE
Am J Vet Res; 2002 Apr; 63(4):506-12. PubMed ID: 11939311
[TBL] [Abstract][Full Text] [Related]
6. Inefficacy of selegiline in treatment of canine pituitary-dependent hyperadrenocorticism.
Braddock JA; Church DB; Robertson ID; Watson AD
Aust Vet J; 2004 May; 82(5):272-7. PubMed ID: 15181926
[TBL] [Abstract][Full Text] [Related]
7. Comparison of results of adrenocorticotropic hormone stimulation and low-dose dexamethasone suppression tests with necropsy findings in dogs: 81 cases (1985-1995).
Van Liew CH; Greco DS; Salman MD
J Am Vet Med Assoc; 1997 Aug; 211(3):322-5. PubMed ID: 9262671
[TBL] [Abstract][Full Text] [Related]
8. Use of aminoglutethimide in the treatment of pituitary-dependent hyperadrenocorticism in the dog.
Pérez AM; Guerrero B; Melián C; Ynaraja E; Peña L
J Small Anim Pract; 2002 Mar; 43(3):104-8. PubMed ID: 11924551
[TBL] [Abstract][Full Text] [Related]
9. Hyperadrenocorticism in a dog due to ectopic secretion of adrenocorticotropic hormone.
Galac S; Kooistra HS; Voorhout G; van den Ingh TS; Mol JA; van den Berg G; Meij BP
Domest Anim Endocrinol; 2005 Apr; 28(3):338-48. PubMed ID: 15760674
[TBL] [Abstract][Full Text] [Related]
10. Urinary corticoid/creatinine ratios in the differentiation between pituitary-dependent hyperadrenocorticism and hyperadrenocorticism due to adrenocortical tumour in the dog.
Galac S; Kooistra HS; Teske E; Rijnberk A
Vet Q; 1997 Mar; 19(1):17-20. PubMed ID: 9225424
[TBL] [Abstract][Full Text] [Related]
11. Concurrent pituitary and adrenal tumors in dogs with hyperadrenocorticism: 17 cases (1978-1995).
Greco DS; Peterson ME; Davidson AP; Feldman EC; Komurek K
J Am Vet Med Assoc; 1999 May; 214(9):1349-53. PubMed ID: 10319177
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of 2 trilostane protocols for the treatment of canine pituitary-dependent hyperadrenocorticism: twice daily versus once daily.
Arenas C; Melián C; Pérez-Alenza MD
J Vet Intern Med; 2013; 27(6):1478-85. PubMed ID: 24118316
[TBL] [Abstract][Full Text] [Related]
13. Carbenoxolone Disodium Treatment for Canine Pituitary-Dependent Hyperadrenocorticism.
Teshima T; Matsumoto H; Okusa T; Uchiyama R; Koyama H
PLoS One; 2016; 11(11):e0166267. PubMed ID: 27824928
[TBL] [Abstract][Full Text] [Related]
14. Plasma concentrations of ACTH precursors correlate with pituitary size and resistance to dexamethasone in dogs with pituitary-dependent hyperadrenocorticism.
Bosje JT; Rijnberk A; Mol JA; Voorhout G; Kooistra HS
Domest Anim Endocrinol; 2002 Jun; 22(4):201-10. PubMed ID: 12044610
[TBL] [Abstract][Full Text] [Related]
15. ACTH-independent hyperadrenocorticism due to food-dependent hypercortisolemia in a dog: a case report.
Galac S; Kars VJ; Voorhout G; Mol JA; Kooistra HS
Vet J; 2008 Jul; 177(1):141-3. PubMed ID: 17572120
[TBL] [Abstract][Full Text] [Related]
16. Use of the urine cortisol-to-creatinine ratio for monitoring dogs with pituitary-dependent hyperadrenocorticism during induction treatment with mitotane (o,p'-DDD).
Randolph JF; Toomey J; Center SA; Scarlett JM; Reimers T; Graham P; Nachreiner RF
Am J Vet Res; 1998 Mar; 59(3):258-61. PubMed ID: 9522940
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis of hyperadrenocorticism in dogs as compared to human diagnostic methods: a review.
Thuróczy J; Balogh L; Huszenicza G; Jánoki GA; Kulcsár M
Acta Vet Hung; 1998; 46(2):157-73. PubMed ID: 9704520
[TBL] [Abstract][Full Text] [Related]
18. Ultrasonography criteria for differentiating ACTH dependency from ACTH independency in 47 dogs with hyperadrenocorticism and equivocal adrenal asymmetry.
Benchekroun G; de Fornel-Thibaud P; Rodríguez Piñeiro MI; Rault D; Besso J; Cohen A; Hernandez J; Stambouli F; Gomes E; Garnier F; Begon D; Maurey-Guenec C; Rosenberg D
J Vet Intern Med; 2010; 24(5):1077-85. PubMed ID: 20666982
[TBL] [Abstract][Full Text] [Related]
19. Use of ACTH stimulation tests to monitor the treatment of canine hyperadrenocorticism.
Dunn KJ; Herrtage ME; Dunn JK
Vet Rec; 1995 Aug; 137(7):161-5. PubMed ID: 8553523
[TBL] [Abstract][Full Text] [Related]
20. Changes in ultrasonographic appearance of adrenal glands in dogs with pituitary-dependent hyperadrenocorticism treated with trilostane.
Mantis P; Lamb CR; Witt AL; Neiger R
Vet Radiol Ultrasound; 2003; 44(6):682-5. PubMed ID: 14703251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
